STOM and cancer: In summary, the reasons for the discrepancy between the existing reports that stomatin can inhibit cancer development and the present study (20–24) may be the same as those of other members of the SPFH superfamily, which have different effects in different cellular environments, and it is worthwhile for us to continue to explore the specific mechanisms of the reasons for the discrepancy.